Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Factor VIIa (FVIIa), bound to tissue factor (TF) at the endo...

Class:IdSummation:9822511
_displayNameFactor VIIa (FVIIa), bound to tissue factor (TF) at the endo...
_timestamp2024-11-20 00:18:58
created[InstanceEdit:9822524] Shamovsky, Veronica, 2022-12-25
literatureReference[LiteratureReference:9841909] The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis
[LiteratureReference:9841912] An all-atom solution-equilibrated model for human extrinsic blood coagulation complex (sTF-VIIa-Xa): a protein-protein docking and molecular dynamics refinement study
[LiteratureReference:9841907] Recent estimates of the structure of the factor VIIa (FVIIa)/tissue factor (TF) and factor Xa (FXa) ternary complex
[LiteratureReference:9671038] Structural biology of factor VIIa/tissue factor initiated coagulation
[LiteratureReference:9929045] Blood coagulation factor X: molecular biology, inherited disease, and engineered therapeutics
modified[InstanceEdit:9929044] Shamovsky, Veronica, 2024-11-20
textFactor VIIa (FVIIa), bound to tissue factor (TF) at the endothelial cell surface catalyzes the cleavage of factor X (FX, F10) with high efficiency within a ternary complex TF:FVIIa:FX (Norledge BV et al., 2003; Venkateswarlu D et al., 2003; reviewed in Lee  CJ et al., 2010; Vadivel K & Bajaj SP 2012). The activated FXa (F10a) consists of a heavy chain (235-488) with the catalytic domain and a light chain (41-179) (reviewed in Camire RM 2021). The amino terminal part of the heavy chain of FX, factor X activation peptide (183-234), is released; this peptide has no known function). Once activated, FXa can remain associated with TF:FVIIa or may dissociate from TF:VIIa:FXa (Norledge BV et al., 2003; Venkateswarlu D et al., 2003). When released, soluble FXa binds to activated factor V (FVa). The formed prothrombinase FXa:FVa complex cleaves prothrombin (factor II) to thrombin (factor IIa), a key enzyme that further catalyzes the conversion of fibrinogen to fibrin, leading to the formation of a stable blood clot.

This Reactome event shows the release of FXa from the TF:FVII:FXa complex.

[Change default viewing format]
No pathways have been reviewed or authored by Factor VIIa (FVIIa), bound to tissue factor (TF) at the endo... (9822511)